Valuation: BioGaia AB

Market Cap 12.57B 1.27B 1.14B 1.05B 954M 1.81B 119B 1.86B 5.01B 63.83B 4.77B 4.67B 202B P/E 2026 *
31.1x
P/E 2027 * 25.7x
Enterprise Value 11.9B 1.2B 1.08B 993M 902M 1.71B 113B 1.76B 4.74B 60.38B 4.51B 4.42B 191B EV / Sales 2026 *
7.05x
EV / Sales 2027 * 6.19x
Free-Float
80.82%
Yield 2026 *
3.3%
Yield 2027 * 2.99%
1 day-0.68%
1 week+3.61%
Current month+2.41%
1 month+4.23%
3 months+9.60%
6 months-5.15%
Current year+16.10%
1 week 118.8
Extreme 118.8
127.4
1 month 115.8
Extreme 115.8
135
Current year 97.5
Extreme 97.5
136.3
1 year 96.2
Extreme 96.2
136.3
3 years 93.2
Extreme 93.2
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 54
Extreme 54
139.7
Manager TitleAgeSince
Chief Executive Officer 60 2023-09-29
Director of Finance/CFO 59 2019-11-04
Chief Operating Officer 49 2020-12-31
Director TitleAgeSince
Chairman 77 2002-12-31
Director/Board Member 46 2014-12-31
Director/Board Member 40 2019-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/26/26 Sell

Director

-20,000 0.0203%
10/26/26 Sell

Director

-10,000 0.0102%
10/26/26 Sell

Director

-10,000 0.0102%
Change 5-day change 1-year change 3-year change Capi.($)
-0.80%+3.61%+23.30%+17.99% 1.28B
+1.58%+1.71%+48.29%+139.82% 1,258B
-0.45%+5.45%+48.97%+90.60% 679B
+0.24%+2.65%+34.24%+111.84% 518B
+0.17%+2.76%+44.07%+69.71% 390B
-0.55%+1.99%+70.09%+45.53% 367B
+0.76%+2.27%+31.59%+60.36% 307B
-1.29%+0.17%+7.63%+33.04% 293B
+0.08%+0.88%+43.77%+74.07% 252B
+0.95%+1.86%+44.38%+124.68% 210B
Average +0.16%+1.39%+39.63%+76.77% 427B
Weighted average by Cap. +0.47%+1.18%+43.73%+96.45%

Financials

2026 *2027 *
Net sales 1.69B 171M 153M 141M 128M 242M 15.99B 249M 672M 8.56B 640M 626M 27.08B 1.92B 194M 174M 160M 146M 276M 18.19B 283M 765M 9.74B 728M 713M 30.8B
Net income 408M 41.28M 37.02M 34.11M 30.98M 58.63M 3.87B 60.27M 163M 2.07B 155M 152M 6.55B 490M 49.49M 44.38M 40.9M 37.15M 70.3M 4.64B 72.26M 195M 2.49B 186M 182M 7.86B
Net Debt -679M -68.61M -61.53M -56.71M -51.5M -97.47M -6.43B -100M -271M -3.45B -258M -252M -10.9B -684M -69.12M -61.99M -57.13M -51.88M -98.19M -6.48B -101M -273M -3.47B -259M -254M -10.98B
Projected Income Statement - Annual - BioGaia AB
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
251
Date Price Change Volume
26-11-10 SEK 123.30 -0.80% 145,804
26-11-09 SEK 124.30 +1.80% 187,954
26-11-06 SEK 122.10 +1.24% 85,952
26-11-05 SEK 120.60 -1.07% 145,750
26-11-04 SEK 121.90 +2.44% 318,110
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - BioGaia AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
124.30SEK
Average target price
152.00SEK
Spread / Average Target
+22.28%
  1. Stock Market
  2. Stocks
  3. BIOG B Stock